Energy & environment · 05/10/2007Updated: 10/17/2026 · 1 min read
NRC Approves License Amendment for Bayer Pharmaceuticals Facility in West Haven, CT
Summary
The U.S. Nuclear Regulatory Commission (NRC) has made available an environmental assessment and finding of no significant impact for a license amendment to terminate Bayer Pharmaceuticals Corporation's facility in West Haven, Connecticut, allowing for unrestricted release of byproducts and materials. This amendment pertains to License No. 06-13053-04.
Original source language: Federal Register — Nuclear Regulatory CommissionOpen original release →